Hypothalamic regulatory pathways and potential obesity treatment targets
- PMID: 16622291
- DOI: 10.1385/endo:29:1:33
Hypothalamic regulatory pathways and potential obesity treatment targets
Abstract
With an ever-growing population of obese people as well as comorbidities associated with obesity, finding effective weight loss strategies is more imperative than ever. One of the challenges in curbing the obesity crisis is designing successful strategies for long-term weight loss and weight-loss maintenance. Currently, weight-loss strategies include promotion of therapeutic lifestyle changes (diet and exercise), pharmacological therapy, and bariatric surgery. This review focuses on several pharmacological targets that activate central nervous system pathways that normally limit food intake and body weight. Though it is likely that no single therapy will prove effective for everyone, this review considers several recent pre-clinical targets, and several compounds that have been in human clinical trials.
Similar articles
-
Obesity research. Tracing leptin's partners in regulating body weight.Science. 2000 Mar 10;287(5459):1738-41. doi: 10.1126/science.287.5459.1738. Science. 2000. PMID: 10755923 No abstract available.
-
Obesity drug pipeline not so fat.Science. 2003 Feb 7;299(5608):849-52. doi: 10.1126/science.299.5608.849. Science. 2003. PMID: 12574616 No abstract available.
-
Hypothalamic peptides as drug targets for obesity.Curr Opin Pharmacol. 2001 Dec;1(6):651-5. doi: 10.1016/s1471-4892(01)00110-2. Curr Opin Pharmacol. 2001. PMID: 11757822 Review.
-
Prospects for obesity treatment: MCH receptor antagonists.Curr Opin Investig Drugs. 2003 Apr;4(4):386-94. Curr Opin Investig Drugs. 2003. PMID: 12808876 Review.
-
Effects of neuropeptides and leptin on nutrient partitioning: dysregulations in obesity.Annu Rev Med. 2001;52:339-51. doi: 10.1146/annurev.med.52.1.339. Annu Rev Med. 2001. PMID: 11160783 Review.
Cited by
-
Defective peripheral nerve development is linked to abnormal architecture and metabolic activity of adipose tissue in Nscl-2 mutant mice.PLoS One. 2009;4(5):e5516. doi: 10.1371/journal.pone.0005516. Epub 2009 May 13. PLoS One. 2009. PMID: 19436734 Free PMC article.
-
The Effect of PPARalpha, PPARdelta, PPARgamma, and PPARpan Agonists on Body Weight, Body Mass, and Serum Lipid Profiles in Diet-Induced Obese AKR/J Mice.PPAR Res. 2007;2007:97125. doi: 10.1155/2007/97125. PPAR Res. 2007. PMID: 17710237 Free PMC article.
-
Dietary patterns only partially explain the effect of short sleep duration on the incidence of obesity.Sleep. 2010 Jun;33(6):753-7. doi: 10.1093/sleep/33.6.753. Sleep. 2010. PMID: 20550015 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical